TOI
TOI
NASDAQ · Health Care

Oncology Institute Inc/The

$3.98
-0.06 (-1.49%)
Financial Highlights (FY 2026)
Revenue
541.33M
Net Income
-65,260,859
Gross Margin
15.2%
Profit Margin
-12.1%
Rev Growth
+25.8%
D/E Ratio
25.95
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 15.2% 15.2% 54.9% 54.9%
Operating Margin -7.2% -6.5% 16.6% 15.3%
Profit Margin -12.1% -11.5% 14.5% 15.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 541.33M 430.31M 77.47M 69.37M
Gross Profit 82.28M 65.41M 42.55M 38.11M
Operating Income -38,867,270 -27,806,472 12.86M 10.62M
Net Income -65,260,859 -46,689,008 11.21M 10.99M
Gross Margin 15.2% 15.2% 54.9% 54.9%
Operating Margin -7.2% -6.5% 16.6% 15.3%
Profit Margin -12.1% -11.5% 14.5% 15.8%
Rev Growth +25.8% +25.8% +0.6% -2.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 191.58M 191.58M 66.92M 74.82M
Total Equity 7.38M 7.38M 141.02M 147.52M
D/E Ratio 25.95 25.95 0.47 0.51
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -45,513,480 -34,370,275 16.24M 13.18M
Free Cash Flow 11.97M 11.86M